US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
FDA approves at-home flu vaccine
The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...
STAT1d
FDA approves first at-home flu vaccine in U.S., a nasal spray
FluMist is the only flu vaccine administered by nasal spray, not injection. It is licensed for individuals between the ages ...
FDA approves first self-administered flu vaccine spray
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the ...
money.rediff1d
ASTRAZENECA PHARMA INDIA LTD. - Launch Of Tremelimumab (Imjudo)
We refer to our earlier communication dated June 1, 2023, intimating the receipt of Import and Market permission in Form CT-20 from Drugs Controller General of India for Tremelimumab (Imjudo) ...
Zacks.com on MSN1d
Pharma Stock Roundup: FDA Approvals for LLY, MRK, AZN & JNJ Drugs
This week, the FDA approved Eli Lilly’s LLY eczema drug, Ebglyss (lebrikizumab), and the expanded use of Novartis’ NVS ...
J&J's Rybrevant Receives FDA Nod for Expanded Use in NSCLC
Johnson & Johnson JNJ announced that the FDA approved a combination therapy involving EFGR/MET inhibitor Rybrevant ...
The greatest British shares to invest in: Their steady and dependable growth is a testament to the power of UK plc
Americans love their Star-Spangled Banner, the French are obsessed with national pride but we Brits have a patriotism problem ...
AOL3d
2 Unstoppable S&P 500 Dividend Stocks to Buy Before They Beat the Market Again
In the first half of 2024, AstraZeneca reported sales that grew more than 10% year over year for 21 different drugs. With ...
AZN Gets FDA Nod for Fasenra Label Expansion in Rare Disease
The FDA okays AstraZeneca's Fasenra for treating adults with eosinophilic granulomatosis with polyangiitis. This is the ...
CEACAM5 Drugs Market Outlook: Rising Cancer Cases and Clinical Trials to Fuel Growth by 2034 | DelveInsight
DelveInsight's CEACAM5 Drugs Market Insights report includes a comprehensive understanding of current treatment practices, ...